Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients
about
Oral lactoferrin treatment of experimental oral candidiasis in miceAntifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed ratsAntifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed ratsEpidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.Comparative genotyping of Candida albicans bloodstream and nonbloodstream isolates at a polymorphic microsatellite locusExperimental induction of fluconazole resistance in Candida tropicalis ATCC 750Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patientsLactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor.Effects of salivary protein flow and indigenous microorganisms on initial colonization of Candida albicans in an in vivo model.Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testingImpact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans.Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agentsFungal biofilm resistance.Lipidomics and in vitro azole resistance in Candida albicans.An MDR1 promoter allele with higher promoter activity is common in clinically isolated strains of Candida albicansMechanisms of Antifungal Drug Resistance.In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry.Drug susceptibilities of yeast cells are affected by membrane lipid composition.Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida.G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.
P2860
Q24680333-4F5B9B3B-D0BD-4F93-87D4-45789BCCE959Q28360707-9EAF2519-5C28-4D83-A613-EE9FCD45C374Q28364102-D0C4C2F3-FDF1-414D-B720-C43ECE980144Q33964121-8C8D7E8C-1201-4542-9133-CAB76494BA3CQ33970644-B4A6E47A-6D8E-45DF-8C91-85AEB20CCC0BQ33979724-31EAA0A3-2BE2-47C8-BD4A-0F2F91EFA4F1Q33983022-038F27BB-66FD-4A5E-A880-53D41D2D86BDQ34007871-8ACFA3D6-10C6-473B-959F-75B35BFFFA74Q34399977-6AE985A2-6926-4F10-8FAC-A395F2A349A5Q34647337-469119D7-A3E8-4DC4-A77C-EBE61E9B7E38Q34721695-D10546F3-1BDD-4AE4-875C-C5AD9D49C53FQ35690629-69392F05-B0C3-4B79-882D-03DB65CE9CB0Q35821475-5A4A4BD5-875F-4A17-9F13-80A063E6DA15Q36596097-BF554361-D8A9-4BCB-B1B4-363874A09C11Q37417553-8E49225E-43B1-481F-AE1D-07DC19DCCF03Q38266675-1EA5BAB3-2ECB-4AF6-8D18-FA7BA703802BQ39651398-C0D5DAF1-B2E0-4951-8C0B-26DD985E561EQ39671060-D3F3E67F-2147-443E-BADF-20A615D08970Q39746465-DBC8A5D0-5226-4B52-B01E-53D68BB6AEF2Q39758166-F9D246FD-B49A-43A0-AA32-213D6E39DC49Q40130606-D51F0E98-F533-43FD-A15D-5DA593B05B83
P2860
Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Multiple resistant phenotypes ...... ciency virus-infected patients
@ast
Multiple resistant phenotypes ...... ciency virus-infected patients
@en
type
label
Multiple resistant phenotypes ...... ciency virus-infected patients
@ast
Multiple resistant phenotypes ...... ciency virus-infected patients
@en
prefLabel
Multiple resistant phenotypes ...... ciency virus-infected patients
@ast
Multiple resistant phenotypes ...... ciency virus-infected patients
@en
P2093
P2860
P356
P1476
Multiple resistant phenotypes ...... ciency virus-infected patients
@en
P2093
J L Lopez-Ribot
M G Rinaldi
R K McAtee
T F Patterson
W R Kirkpatrick
P2860
P304
P356
10.1128/AAC.43.7.1621
P407
P577
1999-07-01T00:00:00Z